Immunosuppressive Drug Discontinuation in Noninfectious Uveitis From Real-Life Clinical Practice: A Survival Analysis-Reference-Cited by-同舟云学术

Immunosuppressive Drug Discontinuation in Noninfectious Uveitis From Real-Life Clinical Practice: A Survival Analysis

Published:2016-09 Issue: Volume:169 Page:1-8
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Abásolo Lydia,Rosales Zulema,Díaz-Valle David,Gómez-Gómez Alejandro,Peña-Blanco Rayma C.,Prieto-García Ángela,Benítez-del-Castillo José Manuel,Pato Esperanza,García-Feijoo Julián,Fernández-Gutiérrez Benjamín,Rodriguez-Rodriguez Luis^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference22 articles.

1. Uveitis: a potentially blinding disease;Durrani;Ophthalmologica,2004

2. Causes and frequency of blindness in patients with intraocular inflammatory disease;Rothova;Br J Ophthalmol,1996

3. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study;Gritz;Ophthalmology,2004

4. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel;Jabs;Am J Ophthalmol,2000

5. Experience with cyclosporine in endogenous uveitis posterior;Hesselink;Transplant Proc,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment exit options for non-infectious uveitis registry: participant characteristics at 3 years;British Journal of Ophthalmology;2024-06-10

2. Real-World Experience in the Use of Immunosuppression for the Management of Inflammatory Eye Disease;Ocular Immunology and Inflammation;2024-02-13

3. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study;BMJ Open;2022-03

4. Das Treatment Exit Options for Uveitis (TOFU) Register: Einbindung von Patienten in die Evidenzgenerierung;Das Gesundheitswesen;2021-11

5. Treatment Exit Options for Non-infectious Uveitis (TOFU): Study Protocol for a Prospective Clinical Registry;Ophthalmic Epidemiology;2021-02-21